Home > News > Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
January 9th, 2007
Mirus Bio Corporation Enters Into Agreement With Pfizer Inc.
Mirus Bio Corporation announced today it has entered into a two year, multimillion dollar agreement with Pfizer Inc. to investigate and optimize gene silencing methods in animal models. The studies will utilize Mirus Bio's nucleic acid delivery platforms to target and suppress the expression of genes of interest to Pfizer.
Harris & Harris Group Issues Letter to Shareholders and Information for Shareholder Call on Tuesday, November 15, 2016 November 14th, 2016
Harris & Harris Group Issues Business Update and Reports Financial Statements as of September 30, 2016 November 9th, 2016
Forge Nano raises $20 million in Series A Funding: Nano coating technology innovator Forge Nano will use funding to expand manufacturing capacity and grow Lithium-Ion battery opportunities November 3rd, 2016
Harris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016 September 30th, 2016
Leti IEDM 2016 Paper Clarifies Correlation between Endurance, Window Margin and Retention in RRAM for First Time: Paper Presented at IEDM 2016 Offers Ways to Reconcile High-cycling Requirements and Instability at High Temperatures in Resistive RAM December 6th, 2016
Tokyo Institute of Technology research: 3D solutions to energy savings in silicon power transistors December 6th, 2016
Physicists decipher electronic properties of materials in work that may change transistors December 6th, 2016
Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016